The World Drug Safety Congress Europe will bring together drug safety, pharmacovigilance, data analytics, epidemiology, and other key players in the biopharma sector. Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally.
The congress is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and will address how to drive pharmacovigilance operations forward.
"The congress is quite ahead in terms of seminar topics with vision from world class leaders!"
“Excellent program covering a wide range of topics and perspectives within drug safety, and great networking opportunities"
"Great presentations, lots of discussions about available technologies, future directions, wide representation from industry and regulators."
"Superb range of speakers and topics and great to have a truly global perspective”
"The roundtables were one of the best things about the conference. They were a great opportunity to compare notes on how certain difficult tasks and interpretations of the regulations are handled.”
"The congress was really great. I really enjoyed it and already recommended it to a friend."
Join our mailing list to receive exclusive content and offers.
By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.